The medical device and diagnostics veteran brings more than two decades of healthcare industry leadership, previously overseeing a $2 billion global division at Boston Scientific.
Beckman Coulter Diagnostics has named Catherine “Cat” Jennings as its new president, tasking the medical device and diagnostics veteran with leading the company’s strategic, operational, and organizational operations.
Jennings joins the clinical diagnostics manufacturer, an operating company of Danaher Corp, from Boston Scientific, where she served as president of vascular therapies. In that role, she oversaw a global commercial and operational business generating approximately $2 billion in annual revenue. Her background spans more than 20 years of leadership in the healthcare sector, with a track record of driving growth, innovation, and transformation across global healthcare organizations.
“Cat is an accomplished healthcare leader with a strong track record of driving growth, fostering innovation and developing high-performing teams,” says Kevin O’Reilly, group executive at Danaher Diagnostics, in a release. “As part of Danaher’s connected diagnostics ecosystem, Beckman Coulter Diagnostics brings together deep expertise, global scale and customer partnership to address some of healthcare’s toughest challenges. Cat’s leadership will help us accelerate innovation and expand the impact of diagnostic solutions around the world.”
Expanding Diagnostic Reach and Clinical Impact
Jennings holds a Bachelor of Science in biology from Georgetown University and a Master of Business Administration from the University of California, Los Angeles. In her new position, she will oversee global operations aimed at supporting hospital, reference, and physician office laboratories.
“It is an honor to join Beckman Coulter Diagnostics, a company with a remarkable legacy of innovation and a mission deeply aligned with my passion for improving patient outcomes,” says Jennings in a release. “Diagnostics play a critical role in helping clinicians make informed decisions. I look forward to collaborating closely with customers, healthcare providers and partners around the world to solve some of the most demanding problems in diagnostics and help bring meaningful innovation to patients faster.”
Headquartered in Brea, California, Beckman Coulter Diagnostics employs more than 10,000 personnel globally. Across clinical settings worldwide, healthcare facilities run more than one million tests per hour on the company’s diagnostic analyzers and laboratory automation platforms, serving an estimated 1.2 billion patients and more than three million clinicians each year.
Photo caption: Catherine Jennings
Photo credit: Beckman Coulter Diagnostics
